VRTX SEC Filings
SEC filings for VRTX. Annual and quarterly reports, 8-K events,
Form 4 insider filings and 13D/G stake disclosures.
| Form | Filed | Accession |
|---|---|---|
| 4van Grunsven JasperEVP, CP and NPPO | Sep 10, 2026 | 0000875320-26-000272EDGAR |
| 4Ambrose KristenSVP & Chief Accounting Officer | Sep 1, 2026 | 0000875320-26-000267EDGAR |
| 8-K | Sep 1, 2026 | 0000875320-26-000264EDGAR |
| 4SACHS BRUCE I | Aug 31, 2026 | 0000875320-26-000261EDGAR |
| 10-Q | Aug 4, 2026 | 0000875320-26-000259EDGAR |
| 8-K | Aug 3, 2026 | 0000875320-26-000256EDGAR |
| 4Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Jul 23, 2026 | 0000875320-26-000253EDGAR |
| 4Sachdev AmitEVP Chief Patient & Ext Af Off | Jul 23, 2026 | 0000875320-26-000251EDGAR |
| 4Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Jul 7, 2026 | 0000875320-26-000245EDGAR |
| 4McKechnie DuncanEVP, Chief Commercial Officer | Jul 7, 2026 | 0000875320-26-000243EDGAR |
| 8-K | Jul 7, 2026 | 0001193125-26-296710EDGAR |
| 4Liu JoyEVP and Chief Legal Officer | Jul 6, 2026 | 0000875320-26-000241EDGAR |
| 4Bozic CarmenEVP and CMO | Jun 30, 2026 | 0000875320-26-000239EDGAR |
| 4Bozic CarmenEVP and CMO | Jun 23, 2026 | 0000875320-26-000237EDGAR |
| 4Bozic CarmenEVP and CMO | Jun 17, 2026 | 0000875320-26-000235EDGAR |
| 4Bozic CarmenEVP and CMO | Jun 9, 2026 | 0000875320-26-000233EDGAR |
| 4Liu JoyEVP and Chief Legal Officer | Jun 3, 2026 | 0000875320-26-000230EDGAR |
| 4Bozic CarmenEVP and CMO | Jun 2, 2026 | 0000875320-26-000228EDGAR |
| 4Bunnage Mark E.EVP, Chief Scientific Officer | May 19, 2026 | 0000875320-26-000226EDGAR |
| 4Bozic CarmenEVP and CMO | May 19, 2026 | 0000875320-26-000225EDGAR |
| 4Bozic CarmenEVP and CMO | May 14, 2026 | 0000875320-26-000222EDGAR |
| SC 13G/AamendedCapital World Investors | May 14, 2026 | 0001422849-26-000080EDGAR |
| SC 13G/AamendedCapital Research Global Investors | May 14, 2026 | 0001422848-26-000067EDGAR |
| 8-K | May 13, 2026 | 0000875320-26-000204EDGAR |
| 4Upadhyay Suketu | May 5, 2026 | 0000875320-26-000193EDGAR |
| 4Thornberry Nancy | May 5, 2026 | 0000875320-26-000191EDGAR |
| 4Schneider Jennifer | May 5, 2026 | 0000875320-26-000189EDGAR |
| 4MCKENZIE DIANA | May 5, 2026 | 0000875320-26-000185EDGAR |
| 4Liu JoyEVP and Chief Legal Officer | May 5, 2026 | 0000875320-26-000183EDGAR |
| 4Garber Alan M | May 5, 2026 | 0000875320-26-000179EDGAR |
| 4Bhatia Sangeeta N. | May 5, 2026 | 0000875320-26-000175EDGAR |
| 10-Q | May 5, 2026 | 0000875320-26-000173EDGAR |
| 8-K | May 4, 2026 | 0000875320-26-000171EDGAR |
| SC 13GVanguard Capital Management | Apr 30, 2026 | 0002100119-26-001217EDGAR |
| 8-K | Apr 29, 2026 | 0000875320-26-000166EDGAR |
| 4Liu JoyEVP and Chief Legal Officer | Apr 3, 2026 | 0000875320-26-000157EDGAR |
| 4Bozic CarmenEVP and CMO | Mar 31, 2026 | 0000875320-26-000149EDGAR |
| 8-K | Mar 31, 2026 | 0000875320-26-000147EDGAR |
| SC 13G/AamendedThe Vanguard Group | Mar 27, 2026 | 0000102909-26-002578EDGAR |
| 4Bozic CarmenEVP and CMO | Mar 17, 2026 | 0000875320-26-000140EDGAR |
| 4McKechnie DuncanEVP, Chief Commercial Officer | Mar 13, 2026 | 0000875320-26-000138EDGAR |
| 4McKechnie DuncanEVP, Chief Commercial Officer | Mar 6, 2026 | 0000875320-26-000136EDGAR |
| 4Liu JoyEVP and Chief Legal Officer | Mar 4, 2026 | 0000875320-26-000134EDGAR |
| 4Kewalramani ReshmaCEO & President | Mar 3, 2026 | 0000875320-26-000129EDGAR |
| 4Bozic CarmenEVP and CMO | Mar 3, 2026 | 0000875320-26-000127EDGAR |
| 4Ambrose KristenSVP & Chief Accounting Officer | Mar 2, 2026 | 0000875320-26-000125EDGAR |
| 4WAGNER CHARLES F JREVP, CO & FO | Feb 26, 2026 | 0000875320-26-000122EDGAR |
| 4Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Feb 26, 2026 | 0000875320-26-000120EDGAR |
| 4Sachdev AmitEVP Chief Patient & Ext Af Off | Feb 26, 2026 | 0000875320-26-000118EDGAR |
| 4McKechnie DuncanEVP, Chief Commercial Officer | Feb 26, 2026 | 0000875320-26-000116EDGAR |
| 4LEIDEN JEFFREY MExecutive Chairman | Feb 26, 2026 | 0001242825-26-000002EDGAR |
| 4Kewalramani ReshmaCEO & President | Feb 26, 2026 | 0000875320-26-000114EDGAR |
| 4Bunnage Mark E.EVP, Chief Scientific Officer | Feb 26, 2026 | 0000875320-26-000112EDGAR |
| 4Bozic CarmenEVP and CMO | Feb 26, 2026 | 0000875320-26-000110EDGAR |
| 4Biller JonathanEVP and Chief Legal Officer | Feb 26, 2026 | 0000875320-26-000108EDGAR |
| 4Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Feb 26, 2026 | 0000875320-26-000106EDGAR |
| 4Ambrose KristenSVP & Chief Accounting Officer | Feb 26, 2026 | 0000875320-26-000104EDGAR |
| 4Sachdev AmitEVP Chief Patient & Ext Af Off | Feb 23, 2026 | 0000875320-26-000102EDGAR |
| 4WAGNER CHARLES F JREVP, CO & FO | Feb 19, 2026 | 0000875320-26-000100EDGAR |
| 4Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Feb 19, 2026 | 0000875320-26-000098EDGAR |
| 4Sachdev AmitEVP Chief Patient & Ext Af Off | Feb 19, 2026 | 0000875320-26-000096EDGAR |
| 4McKechnie DuncanEVP, Chief Commercial Officer | Feb 19, 2026 | 0000875320-26-000094EDGAR |
| 4LEIDEN JEFFREY MExecutive Chairman | Feb 19, 2026 | 0000875320-26-000092EDGAR |
| 4Kewalramani ReshmaCEO & President | Feb 19, 2026 | 0000875320-26-000090EDGAR |
| 4Bunnage Mark E.EVP, Chief Scientific Officer | Feb 19, 2026 | 0000875320-26-000088EDGAR |
| 4Bozic CarmenEVP and CMO | Feb 19, 2026 | 0000875320-26-000086EDGAR |
| 4Biller JonathanEVP and Chief Legal Officer | Feb 19, 2026 | 0000875320-26-000084EDGAR |
| 4Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Feb 19, 2026 | 0000875320-26-000082EDGAR |
| 4Ambrose KristenSVP & Chief Accounting Officer | Feb 19, 2026 | 0000875320-26-000080EDGAR |
| 4WAGNER CHARLES F JREVP, CO & FO | Feb 18, 2026 | 0000875320-26-000078EDGAR |
| 4Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Feb 18, 2026 | 0000875320-26-000076EDGAR |
| 4Sachdev AmitEVP Chief Patient & Ext Af Off | Feb 18, 2026 | 0000875320-26-000074EDGAR |
| 4McKechnie DuncanEVP, Chief Commercial Officer | Feb 18, 2026 | 0000875320-26-000072EDGAR |
| 4Kewalramani ReshmaCEO & President | Feb 18, 2026 | 0000875320-26-000070EDGAR |
| 4Bunnage Mark E.EVP, Chief Scientific Officer | Feb 18, 2026 | 0000875320-26-000068EDGAR |
| 4Bozic CarmenEVP and CMO | Feb 18, 2026 | 0000875320-26-000066EDGAR |
| 4Biller JonathanEVP and Chief Legal Officer | Feb 18, 2026 | 0000875320-26-000064EDGAR |
| 4Bhatia Sangeeta N. | Feb 18, 2026 | 0000875320-26-000062EDGAR |
| 4Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Feb 18, 2026 | 0000875320-26-000060EDGAR |
| 4Ambrose KristenSVP & Chief Accounting Officer | Feb 18, 2026 | 0000875320-26-000058EDGAR |
| 10-K | Feb 13, 2026 | 0000875320-26-000056EDGAR |
| 4WAGNER CHARLES F JREVP, CO & FO | Feb 12, 2026 | 0000875320-26-000054EDGAR |
| 4Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Feb 12, 2026 | 0000875320-26-000052EDGAR |
| 4Sachdev AmitEVP Chief Patient & Ext Af Off | Feb 12, 2026 | 0000875320-26-000050EDGAR |
| 4McKechnie DuncanEVP, Chief Commercial Officer | Feb 12, 2026 | 0000875320-26-000048EDGAR |
| 4Kewalramani ReshmaCEO & President | Feb 12, 2026 | 0000875320-26-000046EDGAR |
| 4Bunnage Mark E.EVP, Chief Scientific Officer | Feb 12, 2026 | 0000875320-26-000044EDGAR |
| 4Bozic CarmenEVP and CMO | Feb 12, 2026 | 0000875320-26-000042EDGAR |
| 4Biller JonathanEVP and Chief Legal Officer | Feb 12, 2026 | 0000875320-26-000040EDGAR |
| 4Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Feb 12, 2026 | 0000875320-26-000038EDGAR |
| 4Ambrose KristenSVP & Chief Accounting Officer | Feb 12, 2026 | 0000875320-26-000036EDGAR |
| SC 13G/AamendedCapital Research Global Investors | Feb 12, 2026 | 0001422848-26-000023EDGAR |
| 8-K | Feb 12, 2026 | 0000875320-26-000034EDGAR |
| 4WAGNER CHARLES F JREVP, CO & FO | Jan 26, 2026 | 0000875320-26-000028EDGAR |
| 4Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Jan 26, 2026 | 0000875320-26-000026EDGAR |
| 4Sachdev AmitEVP Chief Patient & Ext Af Off | Jan 26, 2026 | 0000875320-26-000024EDGAR |
| 4McKechnie DuncanEVP, Chief Commercial Officer | Jan 26, 2026 | 0000875320-26-000022EDGAR |
| 4LEIDEN JEFFREY MExecutive Chairman | Jan 26, 2026 | 0000875320-26-000020EDGAR |
| 4Kewalramani ReshmaCEO & President | Jan 26, 2026 | 0000875320-26-000018EDGAR |
| 4Bozic CarmenEVP and CMO | Jan 26, 2026 | 0000875320-26-000016EDGAR |
| 4Biller JonathanEVP and Chief Legal Officer | Jan 26, 2026 | 0000875320-26-000014EDGAR |
| 4Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Jan 26, 2026 | 0000875320-26-000012EDGAR |
| 4Ambrose KristenSVP & Chief Accounting Officer | Jan 26, 2026 | 0001856587-26-000002EDGAR |
| 4ALTSHULER DAVIDEVP, Chief Scientific Officer | Jan 26, 2026 | 0000875320-26-000010EDGAR |
| 4Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Jan 9, 2026 | 0000875320-26-000004EDGAR |
| 4WAGNER CHARLES F JREVP, CO & FO | Jan 8, 2026 | 0000875320-26-000002EDGAR |
| 4WAGNER CHARLES F JREVP, CO & FO | Dec 5, 2025 | 0000875320-25-000247EDGAR |
| 4Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Dec 5, 2025 | 0000875320-25-000244EDGAR |
| 4LEIDEN JEFFREY MExecutive Chairman | Dec 5, 2025 | 0000875320-25-000242EDGAR |
| 4Biller JonathanEVP and Chief Legal Officer | Dec 5, 2025 | 0000875320-25-000240EDGAR |
| 4CARNEY LLOYD | Nov 20, 2025 | 0000875320-25-000238EDGAR |
| 4Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Nov 19, 2025 | 0000875320-25-000236EDGAR |
| 4LEIDEN JEFFREY MExecutive Chairman | Nov 17, 2025 | 0000875320-25-000234EDGAR |
| 10-Q | Nov 4, 2025 | 0000875320-25-000232EDGAR |
| 8-K | Nov 3, 2025 | 0000875320-25-000230EDGAR |
| 4Biller JonathanEVP and Chief Legal Officer | Oct 3, 2025 | 0000875320-25-000224EDGAR |
Never miss a VRTX filing.
Get an email when VRTX files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.